rs145169006
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002294.3(LAMP2):c.661G>A(p.Gly221Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,209,052 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 848 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002294.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.661G>A | p.Gly221Arg | missense_variant | Exon 5 of 9 | ENST00000200639.9 | NP_002285.1 | |
LAMP2 | NM_001122606.1 | c.661G>A | p.Gly221Arg | missense_variant | Exon 5 of 9 | NP_001116078.1 | ||
LAMP2 | NM_013995.2 | c.661G>A | p.Gly221Arg | missense_variant | Exon 5 of 9 | NP_054701.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00188 AC: 210AN: 111755Hom.: 0 Cov.: 23 AF XY: 0.00183 AC XY: 62AN XY: 33915
GnomAD3 exomes AF: 0.00155 AC: 285AN: 183483Hom.: 1 AF XY: 0.00131 AC XY: 89AN XY: 67921
GnomAD4 exome AF: 0.00224 AC: 2463AN: 1097247Hom.: 0 Cov.: 30 AF XY: 0.00217 AC XY: 786AN XY: 362617
GnomAD4 genome AF: 0.00188 AC: 210AN: 111805Hom.: 0 Cov.: 23 AF XY: 0.00182 AC XY: 62AN XY: 33975
ClinVar
Submissions by phenotype
not specified Benign:5
p.Gly221Arg in LAMP2: This variant is not expected to have clinical significance because it has been identified in 0.2% (84/47999) of European chromosomes, incl uding 30 males, by the Exome Aggregation Consortium (ExAC, http://exac.broadins titute.org/; dbSNP rs145169006). -
Variant summary: LAMP2 c.661G>A (p.Gly221Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0015 in 200310 control chromosomes in the gnomAD database, including 1 homozygote and 95 hemizygotes. The observed variant frequency is approximately 120 fold of the estimated maximal expected allele frequency for a pathogenic variant in LAMP2 causing Cardiomyopathy phenotype (1.3e-05), strongly suggesting that the variant is benign. The variant c.661G>A has been reported in the literature in patients with dilated (DCM) or hypertrophic (HCM) cardiomyopathies, however without evidence for causality (e.g. Mook 2013, Cecconi 2016, Mademont-Soler 2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign (2x)/likely benign(4x). Based on the evidence outlined above, the variant was classified as benign. -
- -
- -
- -
Danon disease Benign:5
- -
- -
- -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
- -
not provided Benign:4
- -
- -
- -
This variant is associated with the following publications: (PMID: 25091525, 23785128, 28074886, 27600940) -
Cardiomyopathy Benign:2
- -
- -
Intellectual disability Uncertain:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at